Lead Product

Lead Product

Preventing and Treating AMR Resistant Topical Infections Utilizing Novel Sustained Release Phage Spray and Patch Systems

Lead Product – Prevention of AMR Infections: 

Sustained release topical designed to prevent AMR infections, with a first indication of significantly reducing pressure ulcer infections (later, labelling for this product will be expanded to include wound care, burn care, and possibly a role in diabetic ulcer care). 25% of all patients in bed for more than 7 days gets a bed sore. Product internally developed.


Important Second Product – Eczema Treatment: 

Treatment of the itching/infection associated with eczema. We will initially develop a hospital product (that can be stored at 4 degrees) and latter a consumer product that can be stored at 37 degrees. Product internally developed.


Important Third Product – Acne Treatment: 

First lysin to be developed to treat p.acnes. We will initially develop a hospital product that is combined with ClyO (that can be stored at 4 degrees) and latter a consumer product that can be stored at 37 degrees. Product internally developed. 

Spray-Patch:

Pro-Patch:

The Cost of Goods of Phagelux Products is Low:

Low COGs has three key benefits:

(1) End pricing will be attractive for health systems since it will likely cut costs out of the market  (cheaper to use then not use).

(2) It is attractive to insurers since it will result in better patient outcomes at a low cost.

(3) Even if not reimbursed, it will be affordable to all patients in almost all global markets.


COGs: About 20 RMB per spray canister; patch is much lower.

Estimate Wholesale Sale Price: 80RMB in China and significantly higher in Western markets.

Technical Support: 赛泊斯 | Admin Login